|
National Stock Number(NSN): 6505-01-307-3272 (6505013073272, 013073272)
| NIIN: |
01-307-3272 |
Item Name: |
FAT EMULSION INJECTION |
INC: |
35184
|
| FSC: |
6505
|
Assignment Date: |
Sep-09-1989 |
CRIT: |
X |
IIG: |
35184 |
| ISC: |
5 |
Date Standardized: |
Sep-09-1989 |
HMIC: |
P |
DODIC: |
|
| NSC: |
0 |
Cancellation Date: |
|
PMIC: |
A |
FIIG: |
A45100 |
| ESD: |
|
Schedule B: |
3004.90.9270 |
DEMIL: |
A |
DEMIL INT: |
1 |
| TIIC: |
1 |
Originator: |
97 |
ADPEC: |
|
RPDMRC: |
|
| Part Number |
CAGE |
Company |
Status |
RN CC |
RN VC |
DAC |
RN AAC |
RN FC |
RN SC |
RN JC |
SADC |
HCC |
MSDS |
|
A89G070 |
66732
|
DEPARTMENT OF THE ARMY U S ARMY MEDICAL MATERIAL AGENCY MCMR-MMO-SA |
C |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
INTRALIPID |
1G026
|
BAXTER HEALTHCARE CORPORATION |
C |
5 |
1 |
4 |
KX |
|
|
|
|
|
|
|
NDC00338-0491-02 |
0B4V2
|
BAXTER HEALTHCARE CORP |
C |
3 |
9 |
4 |
KX |
|
|
|
|
|
|
|
1A6022 |
1G026
|
BAXTER HEALTHCARE CORPORATION |
H |
3 |
2 |
|
|
|
|
|
|
|
|
|
NDC00161-0490-23 |
1G026
|
BAXTER HEALTHCARE CORPORATION |
H |
3 |
1 |
|
|
|
|
|
|
|
|
| MOEC |
SOS |
A A C |
R C |
S L C |
CIIC |
U P Q |
U S C |
Unit Price |
UI |
UICF |
MCD |
Action Date |
C/H |
| DA |
JDC |
L |
|
M |
|
1 |
|
$80.00 |
PG |
|
C2201X- |
|
H |
| DM |
S9M |
Y |
Z |
M |
U |
1 |
M |
$84.32 |
PG |
|
13M2--1 |
Jun-01-1994 |
H |
| DN |
SMS |
V |
|
M |
U |
1 |
N |
$84.32 |
PG |
|
9L----- |
Nov-01-2007 |
H |
| DS |
SMS |
Y |
|
M |
U |
1 |
D |
$84.32 |
PG |
|
------- |
Jun-01-1994 |
H |
| DS |
SMS |
Y |
|
M |
U |
1 |
I |
$84.32 |
PG |
|
------- |
Jun-01-1994 |
C |
| VA |
JVS |
I |
|
M |
U |
A |
V |
$0.00 |
PG |
|
------- |
Nov-01-1989 |
C |
| MOEC |
PC |
Phrase |
QPA |
UOM |
OOU |
JTC |
| DA |
K |
U/I CONTAINS 10EA |
|
|
|
|
| DM |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DN |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
V |
DISCONTINUED W/O REPLACEMENT |
000 |
|
|
|
| DS |
V |
DISCONTINUED WITHOUT REPLACEMENT |
000 |
|
|
|
| VA |
K |
U/I CONTAINS 10 EA |
000 |
|
|
|
Technical Characteristics Information
| MRC |
Requirement Statement |
Reply Statement |
| AKJA |
ACTIVE MEDICAMENT MEDICINAL STRENGTH |
2.250 PERCENTAGE, W/V GLYCERIN ACTIVE INGREDIENT AND 1.200 PERCENTAGE, W/V PHOSPHOLIPIDS ACTIVE INGREDIENT AND 20.000 PERCENTAGE, W/V SOYBEAN OIL ACTIVE INGREDIENT |
| CQCT |
PRIMARY CONTAINER TYPE |
BOTTLE, GLASS |
| CRLK |
PRIMARY CONTAINER CONTENT QUANTITY |
250.000 MILLILITERS |
| CSCW |
TOTAL PRIMARY CONTAINER QUANTITY |
10 |
| FEAT |
SPECIAL FEATURES |
WITHOUT ADMINISTRATION SET |
| MOE Rule |
Former MOER |
Effective |
AMC |
AMSC |
IMC |
IMCA |
Collaborators |
Receivers |
| V542 |
|
Apr-01-1991 |
3 |
Z |
|
|
54 |
54 |
| Description: |
DRUGS/MEDICINES/VITAMINS NOI |
Originating Activity: |
KX |
| Hazardous Material: |
|
National Motor Freight Classification Number: |
058770 |
| Less Than One Truckload: |
W |
NMFC Sub-Item: |
Z |
| Uniform Freight Classification Number: |
33400 |
Rail Variance Code: |
|
| Less Than One Carload: |
|
Water Commodity Code: |
532 |
| Type of Cargo Code: |
Z |
Special Handling Code: |
9 |
| Air Commodity Special Handling Code: |
MZ |
Air Dimension Code: |
A |
|